- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04046835
The Effect of Patient Position on the External Haller Index Value Among Patients With Pectus Excavatum (POSITION)
July 1, 2020 updated by: Zuyderland Medisch Centrum
Pectus excavatum is the most common anterior chest wall deformity, affecting up to 1:400 of newborns.
The current gold standard to quantify the extent of deformity is by calculating the Haller Index based on a Computed Tomography (CT)-scan.
However, as such scans inescapably imply exposure to ionizing radiation, novel imaging techniques have been investigated.
Three-dimensional optical surface scanning is a promising new technique to acquire the trunks' three-dimensional (3D) surface topography.
Based on this 3D scan, one is able to calculate the external Haller Index that is known to highly correlate with the conventional gold standard Haller Index that is based on internal measures.
Both the conventional and external Haller Index are known to be affected by the respiratory phase in which the scan is acquired, however, what is the effect of patient position on the external Haller Index, and if affected, how should one correct for this phenomenon?
To investigate this, a retrospective single-centre pilot study will be conducted.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
12
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Limburg
-
Heerlen, Limburg, Netherlands, 6419PC
- Zuyderland Medical Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients that received a three-dimensional optical surface scan to quatify their pectus deformity utilizing the external Haller Index.
Patients were retrospectively recruited from the 3DPECTUS study (METCZ20190048; NCT03926078).
Description
Inclusion Criteria:
- Patients that received a three-dimensional optical surface scan to quantify their pectus deformity
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient position
Time Frame: 5 months
|
The effect of patient position on the value of the external Haller Index, based on 3D scans.
|
5 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Manual versus automatic alignment of patient position
Time Frame: 5 months
|
If there is a significant effect of patient position on the external Haller Index, the ideal correction method is investigated (manual alignment versus automatic, computer-based alignment)
|
5 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
January 1, 2021
Primary Completion (Anticipated)
March 1, 2021
Study Completion (Anticipated)
April 1, 2021
Study Registration Dates
First Submitted
August 2, 2019
First Submitted That Met QC Criteria
August 5, 2019
First Posted (Actual)
August 6, 2019
Study Record Updates
Last Update Posted (Actual)
July 2, 2020
Last Update Submitted That Met QC Criteria
July 1, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- METCZ20190106
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pectus Excavatum
-
Hacettepe UniversityCompletedFunnel Chest | Pectus Excavatum | Pectus Excavatum Deformity | Chest DeformitiesTurkey
-
Galderma R&DPharma Consulting Group ABCompletedPectus Excavatum DeformityFrance, Sweden
-
Children's Health System, Inc.Walter Lorenz Surgical CorporationUnknownRepair of Pectus ExcavatumUnited States, Canada
-
Erik de LoosCompleted
-
Ankara Etlik City HospitalRecruitingPectus Excavatum DeformityTurkey (Türkiye)
-
Acibadem UniversityUnknownPhysical Disability | Psychosocial Impairment | Pectus DeformityTurkey
-
Gaziosmanpasa Research and Education HospitalCompletedPectus Excavatum | Pectus Carinatum | Pectus Deformity | Pectus AbnormalitiesTurkey (Türkiye)
-
Başakşehir Çam & Sakura City HospitalRecruitingPectus ExcavatumTurkey
-
Baylor College of MedicineTerminatedPectus ExcavatumUnited States
-
Medical University InnsbruckCompletedPectus Excavatum | Pectus CarinatumAustria